Recalls / —
—#104072
Product
Plum A+ Single Channel Infusion Pumps; Hospira, Inc., Lake Forest, IL 60045; the pumps were sold under the following configurations: a) list 11971 b) list 11973 - software version 10.3 c) list 12391 - software version 11.3 d) list 20679 - Hospira MedNet Software e) list 20792 - Driver The Plum A+ dual-line volumetric infusion system designed to meet the growing demand for hospital-wide, as well as alternate site and home healthcare, standardization. With their primary line, secondary line, and piggyback fluid delivery capability, the Plum A+ is suited for a wide range of medical/surgical and critical care applications. Full compatibility with LifeCare Plum Series administration sets and accessories and the LifeShield needleless protection systems makes the Plum A+ a convenient and cost-effective infusion system.
- FDA product code
- FRN — Pump, Infusion
- Device class
- Class 2
- Medical specialty
- General Hospital
- 510(k) numbers
- K011442, K042081, K070398, K982159
- Affected lot / code info
- a) list 11971- serial numbers 0013120799 through 0099072300; b) list 11973 - serial numbers 0012570058 through 0012573663; c) list 12391 - serial numbers 0000073363 through 0999948294; d) list 20679 - serial numbers 0015441179 through 0015459047; e) list 20792 - serial numbers 0016061555 through 0026347395
Why it was recalled
Hospira has received reports of incorrect seating of the regulator closer on the Plum A+ Infusion Pumps. If the regulator closer does not close the flow regulator actuator when the pump door is opened, and if the clinician has not engaged the clamp prior to opening the cassette door, unrestricted flow may occur.
Root cause (FDA determination)
Nonconforming Material/Component
Action the firm took
Hospira, Inc. sent an "URGENT DEVICE RECALL" letter dated September 16, 2011 to all affected customers. The letter describes the product, problem and actions to be taken by the customers. The letter instructs customers on how to prevent occurrences of continuous recycling/rebooting during start-up. A reply form was attached to the letter for customers to complete and return via fax to 1-888-345-5358. Contact Hospira Advanced Knowledge Center at 1-800-241-4002, option 4, for technical assistance or information regarding this notice.
Recalling firm
- Firm
- Hospira Inc.
- Address
- 275 N Field Dr, Lake Forest, Illinois 60045-2579
Distribution
- Distribution pattern
- Worldwide Distribution-USA (nationwide) including Puerto Rico and the U. S. Virgin Islands and countries of Argentina, Australia, Bahamas, Barbados, Belgium, Brazil, Canada, Chile, Colombia, Costa Rica, Denmark, Dominican Republic, Ecuador, France, Greece, Hong Kong, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Korea, Kuwait, Lebanon, Libya, Malaysia, Mexico, Netherlands, New Zealand, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Saudi Arabia, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, United kingdom, United Arab Emirates, Uruguay and Vietnam.
Timeline
- Recall initiated
- 2011-09-16
- Posted by FDA
- 2011-09-29
- Terminated
- 2016-11-07
- Status
- —
Source: openFDA Device Recall endpoint. Recall record ID #104072. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.